Segment Information - Schedule of Consolidated Net Loss (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Significant segment expenses | ||||||||
| General and administrative | $ 577,942 | $ 729,572 | $ 6,790,271 | $ 1,579,854 | ||||
| Research and development | 400,536 | 238,700 | 721,807 | 238,700 | ||||
| Exploration and evaluation | 561,030 | 561,030 | ||||||
| Impairment expense | 2,045,253 | |||||||
| Reconciliation of net loss | ||||||||
| Change in fair value of warrant liabilities | (1,815,233) | 121,476 | 499,120 | 107,961 | ||||
| Consolidated net loss | 3,685,060 | $ 13,857,203 | 4,093,231 | $ 2,233,982 | 17,542,263 | 6,327,213 | ||
| Reportable Subsegments [Member] | ||||||||
| Significant segment expenses | ||||||||
| General and administrative | [1] | 577,942 | 729,572 | 6,790,271 | 1,579,854 | |||
| Research and development | 400,536 | 238,700 | 721,807 | 238,700 | ||||
| Exploration and evaluation | 561,030 | 561,030 | ||||||
| Professional fees | 3,952,434 | 924,580 | 6,931,123 | 1,661,266 | ||||
| Interest expense (income) | 4,888 | 1,760,025 | 6,503 | 2,313,962 | ||||
| Impairment expense | 2,045,253 | |||||||
| Other segment items | 3,463 | 318,878 | (12,843) | 425,470 | ||||
| Total operating and segment expenses | 5,500,293 | 3,971,755 | 17,043,143 | 6,219,252 | ||||
| Reconciliation of net loss | ||||||||
| Change in fair value of warrant liabilities | (1,815,233) | 121,476 | 499,120 | 107,961 | ||||
| Consolidated net loss | 3,685,060 | 4,093,231 | 17,542,263 | 6,327,213 | ||||
| Biotech [Member] | ||||||||
| Significant segment expenses | ||||||||
| General and administrative | [1] | 78,505 | 729,572 | 6,166,587 | 1,579,854 | |||
| Research and development | 400,536 | 238,700 | 721,807 | 238,700 | ||||
| Exploration and evaluation | ||||||||
| Professional fees | 726,341 | 924,580 | 3,496,522 | 1,661,266 | ||||
| Interest expense (income) | 4,888 | 1,760,025 | 6,503 | 2,313,962 | ||||
| Impairment expense | 2,045,253 | |||||||
| Other segment items | 3,463 | 318,878 | (12,843) | 425,470 | ||||
| Total operating and segment expenses | 1,213,733 | $ 3,971,755 | 12,423,829 | $ 6,219,252 | ||||
| Mining [Member] | ||||||||
| Significant segment expenses | ||||||||
| General and administrative | [1] | 499,437 | 623,684 | |||||
| Research and development | ||||||||
| Exploration and evaluation | 561,030 | 561,030 | ||||||
| Professional fees | 3,226,093 | 3,434,601 | ||||||
| Interest expense (income) | ||||||||
| Impairment expense | ||||||||
| Other segment items | ||||||||
| Total operating and segment expenses | $ 4,286,560 | $ 4,619,315 | ||||||
| ||||||||
| X | ||||||||||
- Definition The amount of impairment expense. No definition available.
|
| X | ||||||||||
- Definition Amount of professional fees other. No definition available.
|
| X | ||||||||||
- Definition Exploration expenses (including prospecting) related to oil and gas producing entities and would be included in operating expenses of that entity. Costs incurred in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: (i) Costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or "G&G" costs. (ii) Costs of carrying and retaining undeveloped properties, such as delay rentals, ad valorem taxes on properties, legal costs for title defense, and the maintenance of land and lease records. (iii) Dry hole contributions and bottom hole contributions. (iv) Costs of drilling and equipping exploratory wells. (v) Costs of drilling exploratory-type stratigraphic test wells. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|